PRESS RELEASE published on 02/19/2026 at 18:00, 2 months 15 days ago THX Pharma publie sa position de trésorerie au 31 décembre 2025 THX Pharma annonce une trésorerie disponible de 7,764 k€ au 31 décembre 2025, renforcée par un accord avec Biocodex pour un versement de 12 M€ en mars 2026. Prochaine publication : Résultats financiers annuels le 28 avril 2026 Résultats Financiers Trésorerie Accord THX Pharma Biocodex
BRIEF published on 02/12/2026 at 18:05, 2 months 22 days ago THX Pharma Announces Webinar on Strategic Agreement with Biocodex Webinar Batten-1 Strategic Agreement THX Pharma Biocodex
BRIEF published on 02/12/2026 at 18:05, 2 months 22 days ago THX Pharma et Biocodex concluent un accord stratégique majeur Webinaire Accord Stratégique THX Pharma Médicaments Neurologiques Biocodex
BRIEF published on 02/12/2026 at 18:05, 2 months 22 days ago THX Pharma annonce un webinaire sur son accord stratégique avec Biocodex Webinaire Accord Stratégique Batten-1 THX Pharma Biocodex
BRIEF published on 02/12/2026 at 18:05, 2 months 22 days ago THX Pharma and Biocodex conclude a major strategic agreement Webinar Strategic Agreement THX Pharma Neurological Medications Biocodex
PRESS RELEASE published on 02/12/2026 at 18:00, 2 months 22 days ago THX Pharma to Host a Webinar to Discuss Its Strategic Agreement with Biocodex THX Pharma to host webinar discussing strategic agreement with Biocodex, including licensing terms and development outlook. Webcast on February 17, 6:00 p.m. CET. More info at theranexus.com Webinar Strategic Agreement Neurological Diseases THX Pharma Biocodex
PRESS RELEASE published on 02/12/2026 at 18:00, 2 months 22 days ago THX Pharma organise un webinaire pour commenter son accord stratégique avec Biocodex THX Pharma annonce un webinaire pour discuter de son accord avec Biocodex portant sur le développement de traitements pour les maladies neurologiques rares Webinaire Accord Stratégique Maladies Neurologiques Rares THX Pharma Biocodex
BRIEF published on 02/10/2026 at 18:05, 2 months 24 days ago Accord Stratégique entre THX Pharma et Biocodex pour trois Maladies Rares Maladies Rares Accord De Licence THX Pharma Biocodex Batten-1 Et TX01
BRIEF published on 02/10/2026 at 18:05, 2 months 24 days ago Strategic agreement between THX Pharma and Biocodex for three rare diseases Rare Diseases License Agreement THX Pharma Biocodex Batten-1 And TX01
BRIEF published on 02/10/2026 at 18:05, 2 months 24 days ago Accord de licence stratégique pour les traitements des maladies rares Accord Stratégique Maladies Rares Accord De Licence THX Pharma Biocodex
Published on 05/06/2026 at 23:30, 1 hour 50 minutes ago Stabilis Solutions Announces First Quarter 2026 Results
Published on 05/06/2026 at 23:05, 2 hours 15 minutes ago Zomedica Announces Record First Quarter Revenue of $8.8 Million, Reflecting 35% Annual Growth; and $47.5 Million in Liquidity
Published on 05/06/2026 at 23:00, 2 hours 20 minutes ago Green Bridge Metals Strengthens Technical and Strategic Team as 2026 Work Programs Advance
Published on 05/06/2026 at 22:10, 3 hours 10 minutes ago Banyan Gold Announces Closing of $46.5 Million Private Placement
Published on 05/06/2026 at 22:05, 3 hours 15 minutes ago Pivotree Announces Resignation of Board Director Patrick Meneley
Published on 05/07/2026 at 00:47, 33 minutes ago Blue Cap AG expands portfolio through the acquisition of Janoschka AG
Published on 05/07/2026 at 00:43, 36 minutes ago EQS-Adhoc: Blue Cap AG Acquires Janoschka AG and Adjusts Forecast Due to Transaction
Published on 05/06/2026 at 20:32, 4 hours 48 minutes ago EQS-Adhoc: Kontron AG: ADHOC Kontron AG / Potential Public Takeover Bid by Ennoconn Corporation
Published on 05/06/2026 at 20:22, 4 hours 58 minutes ago EQS-Adhoc: ams-OSRAM AG: ams OSRAM delivers strong Q1 results, enters AI market through a development agreement with a leading AI photonics customer and sees path to positive Free Cash Flow in 2027
Published on 05/06/2026 at 19:18, 6 hours 2 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 05/06/2026 at 18:00, 7 hours 20 minutes ago Mise à disposition des documents relatifs à l'AG du 4 juin 2026
Published on 05/06/2026 at 18:00, 7 hours 20 minutes ago Access to information in respect of the General Shareholders’ Meeting to be held on June 4, 2026
Published on 05/06/2026 at 18:00, 7 hours 20 minutes ago Information concerning the total number of voting rights and shares in the share capital as of April 30, 2026
Published on 05/06/2026 at 18:00, 7 hours 20 minutes ago Informations relatives au nombre total de droits de vote et d’actions composant le capital social au 30 avril 2026
Published on 05/06/2026 at 17:45, 7 hours 35 minutes ago Information concerning the total number of voting rights and shares 2026 04 30
